MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae | Zendy

Mercedes Delgado-Valverde | Zendy; Adoración Valiente-Méndez | Zendy; Eva Torres | Zendy; Benito Almirante | Zendy; Sílvia Gómez-Zorrilla | Zendy; Núria Borrell | Zendy; Ana Isabel Aller-García | Zendy; M. Gurguí | Zendy; Manel Almela | Zendy; Mercedes Sanz | Zendy; Germán Bou | Zendy; Luis MartínezMartínez | Zendy; Rafael Cantón | Zendy; José Antonio Lepe | Zendy; Manuel Causse | Zendy; Belén GutiérrezGutiérrez | Zendy; Álvaro Pascual | Zendy; Jesús RodríguezBaño | Zendy

Open Access

MIC of amoxicillin/clavulanate according to CLSI and EUCAST: discrepancies and clinical impact in patients with bloodstream infections due to Enterobacteriaceae

Author(s) -

Mercedes Delgado-Valverde,

Adoración Valiente-Méndez,

Eva Torres,

Benito Almirante,

Sílvia Gómez-Zorrilla,

Núria Borrell,

Ana Isabel Aller-García,

M. Gurguí,

Manel Almela,

Mercedes Sanz,

Germán Bou,

Luis MartínezMartínez,

Rafael Cantón,

José Antonio Lepe,

Manuel Causse,

Belén GutiérrezGutiérrez,

Álvaro Pascual,

Jesús RodríguezBaño

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkw562

Subject(s) - medicine , amoxicillin , clavulanic acid , microbiology and biotechnology , antibiotics , biology

To compare results of amoxicillin/clavulanate susceptibility testing using CLSI and EUCAST methodologies and to evaluate their impact on outcome in patients with bacteraemia caused by Enterobacteriaceae.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research